https://www.pharmaceutical-technology.com/features/talking-generics-in-the-uk-with-mylans-jean-yves-brault/ 2018-06-19T12:51:57+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/fda-awards-prv-not-profits-river-blindness-treatment/ 2018-06-19T10:11:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-approves-immunooncology-agent-opdivo-previously-treated-nsclc/ 2018-06-19T10:50:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/celltrion-resubmits-marketing-approval-fda-trastuzumab-biosimilar/ 2018-06-19T11:06:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/university-leicester-finds-new-way-assess-men-b-vaccine-effectiveness/ 2018-06-19T11:07:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-court-issues-restraint-order-dr-reddys-new-drug/ 2018-06-18T15:40:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-finds-jakavi-can-help-real-world-blood-cancer-patients/ 2022-07-11T08:55:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-suboxone-generic-variant-treat-opioid-dependence/ 2018-06-18T10:22:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/eular-2018-key-pipeline-developments-psoriatic-arthritis/ 2018-06-15T14:18:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/johnson-johnson-sells-lifescan-private-equity/ 2021-06-01T09:17:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/innovators-watch-tlas-healthtech-innovator-conference/ 2018-06-15T10:53:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/lanabecestat-termination-another-blow-bace-inhibitors/ 2018-06-15T09:47:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/eular-2018-focus-infliximab-biosimilars-rheumatoid-arthritis/ 2018-06-15T09:48:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pfizers-blockbuster-drug-lyrica-comes-off-patent-2018/ 2024-05-10T07:19:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/report-gene-therapies-may-see-success-regulatory-oncology-updates/ 2018-06-15T09:15:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sage-shionogi-advance-depression-drug-asia/ 2018-06-15T10:22:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-mas-week-alexion-pharmaceuticals-recipharm-astrazeneca/ 2018-07-27T06:35:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mercks-keytruda-gets-us-approval-pmbc-lymphoma/ 2018-06-15T11:23:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/ten-promising-cancer-drugs-trialled/ 2022-07-11T08:55:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-fast-tracks-nordic-nanovectors-betalutin-follicular-lymphoma/ 2018-06-14T11:44:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eisai-set-dementia-research-facility-us/ 2018-06-14T11:10:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uks-nice-issues-positive-guidance-janssens-tremfya/ 2018-06-14T11:45:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/formula-success-inside-swiss-pharma/ 2020-01-27T05:11:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/northwest-bios-dcvax-l-hype-warranted-glioblastoma-patients/ 2022-07-11T08:55:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-suggests-new-reimbursement-idea-antimicrobial-drugs/ 2018-06-13T13:58:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/asco-data-sees-mercks-keytruda-pull-ahead-roches-tecentriq-lung-cancer/ 2018-06-13T11:00:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/single-country-studies-dominate-immuno-oncology-trials-2008-2017/ 2018-06-13T10:52:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/eli-lillys-olumiant-will-far-among-jak-inhibitors/ 2018-06-13T10:02:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cancer-research-uk-initiate-trial-for-immunotherapy-vaccine/ 2018-06-13T11:45:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/denali-abcellera-collaborate-treating-neurodegenerative-disease/ 2018-06-13T13:38:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nih-maxcyte-develop-new-sickle-cell-disease-therapies/ 2022-12-09T12:29:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/efficacy-bar-unclear-celgenes-phase-iii-abraxane-gemcitabine/ 2018-06-12T14:31:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/gut-instinct-common-drugs-affect-microbiome/ 2018-06-12T11:13:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/unmet-needs-must-addressed-optimise-ais-management/ 2018-06-12T11:07:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/asco-2018-roches-polatuzumab-vedotin-results-show-promise-dlbcl/ 2018-06-12T10:15:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-abbvies-venclexta-chronic-lymphocytic-leukaemia/ 2018-06-12T09:50:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-receives-european-clearance-lung-cancer-drug/ 2018-06-12T11:00:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-pasteur-translate-bio-develop-new-mrna-vaccines/ 2018-06-12T09:42:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/unlocking-cell-free-protein-synthesis-biotechs-next-big-ticket/ 2018-06-11T16:10:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/asco-2018-mercks-keytruda-top-first-line-nsclc/ 2018-06-11T15:06:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/opportunity-gene-therapies-oncology/ 2018-06-12T11:05:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-wins-appeal-cma-fine-epilepsy-drug-price/ 2018-06-11T11:15:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/asco-2018-evolving-role-supportive-care-oncology/ 2018-06-11T11:13:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/astrazenecas-fasenra-find-use-niche-asthma-copd-overlapping-group/ 2023-01-04T10:12:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/uk-builds-worlds-first-fully-automated-drug-discovery-facility/ 2018-06-15T09:07:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-ema-accept-marketing-application-pfizers-talazoparib/ 2018-06-11T10:51:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-chinese-scientists-partner-new-medicines-epidemics/ 2018-06-11T11:48:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ge-provides-flexfactory-platform-xiangxue-pharmaceutical/ 2018-06-11T10:29:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aduro-starts-phase-1b-trial-immunotherapy-treatment-lung-cancer/ 2022-07-11T08:55:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/asco-2018-lag-3-next-checkpoint-target/ 2018-06-08T10:49:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/asco-2018-will-jcar017-become-third-car-t-product-lymphoma/ 2018-06-08T10:43:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/asco-2018-roche-discusses-tmb-predictive-biomarker-nsclc/ 2018-06-08T10:21:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-optinose-kitov-pharma-clovis-oncology/ 2018-07-27T06:35:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-partners-boston-university-tackle-lung-cancer/ 2018-06-08T10:28:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genentech-microbiotica-develop-new-ibd-medicines/ 2018-06-08T10:44:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-intermediate-capital-group-novartis/ 2018-07-27T06:35:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogen-acquires-licence-japanese-firm-tms-stroke-asset/ 2018-06-08T10:36:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/positive-vaccine-study-vbi-looks-untapped-congenital-cmv-market/ 2018-06-07T14:51:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-files-legal-complaint-biodefense/ 2018-06-07T13:45:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/can-ai-reveal-complex-patterns-biological-data/ 2019-12-23T10:54:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/holistic-approach-disease-may-bring-true-pharma-innovation/ 2018-06-07T10:10:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/shorter-antibiotic-courses-health-benefits-evidence-needed/ 2018-06-07T09:34:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-hookipa-develop-new-hiv-hbv-drugs/ 2018-06-07T11:31:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/axovant-buys-rights-oxford-biomedicas-parkinsons-candidate/ 2018-06-07T11:23:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fully-automated-facility-drug-discovery-built-uk/ 2018-06-08T10:03:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/bipolar-disorder-understanding-a-multifaceted-mental-condition/ 2018-06-06T15:34:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-rejects-ipsens-cabometyx-treatment-renal-cancer-nhs/ 2018-06-06T13:42:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/biosimilar-interchangeability-studies-limited-benefit-us-uptake/ 2018-06-06T12:27:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/us-china-trade-war-wipe-us-based-generics-manufacturing/ 2018-06-07T09:39:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nihs-study-shows-positive-outcomes-experimental-hiv-vaccine/ 2018-06-06T10:21:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-warns-illicit-online-opiod-marketers/ 2018-06-06T11:34:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mylan-biocons-biosimilar-neulasta-gains-fda-approval/ 2023-03-08T09:49:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/visualising-biologics-discovery-dealing-complex-data/ 2018-06-05T16:03:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-merck-record-improved-survival-combination-treatment-mcrpc/ 2018-06-05T15:41:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/can-cimzia-approval-secure-ucbs-position-immuno-dermatology/ 2018-06-05T13:09:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/g-protein-coupled-receptor-signaling-set-dominate-womens-health-therapy-market/ 2018-06-05T12:37:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-unveils-new-data-ustekinumab-treatment-crohns-disease/ 2018-06-05T14:23:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/asco-2018-combinations-vs-single-agent-melanoma-immunotherapy/ 2018-06-05T10:56:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/asco-2018-revlimid-results-superior-safety-worth-cost/ 2018-06-05T10:50:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/metformin-can-reduce-deaths-heart-circulatory-diseases/ 2023-05-22T08:41:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lillys-olumiant-gets-us-approval-treat-rheumatoid-arthritis/ 2018-06-05T11:00:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/european-chmp-recommends-akceas-rare-disease-drug/ 2018-06-05T10:53:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/may-2018-top-news-stories-pharma/ 2018-06-05T10:24:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/exelixis-invenra-partner-oncology-drug-development/ 2018-06-04T12:57:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/deployment-mercks-rvsv-zebov-combat-ebola-marks-crossroads-vaccine-rd/ 2018-06-04T12:47:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/study-suggests-breast-cancer-patients-no-benefit-chemotherapy/ 2018-06-04T13:09:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-signs-oncology-collaborations-md-anderson/ 2018-06-04T10:42:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-divests-stake-joint-venture-gsk/ 2018-06-04T10:35:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-premier-develop-solutions-c-diff-infection/ 2018-06-04T10:25:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-releases-draft-guidance-policies-improve-generic-drugs-access/ 2018-06-01T14:19:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/gene-therapies-miraculous-cures-sustainable-business-model/ 2018-06-01T10:50:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/manipulating-fda-safety-protocols-maintain-market-dominance-right/ 2018-06-01T10:07:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/schrodinger-canadas-cdrd-partner-develop-cancer-biologics/ 2018-06-01T11:12:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-reports-positive-data-esketamine-treat-depression/ 2018-06-01T11:12:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-sanofi-alibaba-group-amneal-pharmaceuticals/ 2018-07-27T06:35:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/indias-use-unapproved-antibiotics-undermine-global-health/ 2018-05-31T14:35:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abivax-believes-made-progress-towards-hiv-cure/ 2018-05-31T14:21:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-accepts-new-drug-application-novartis-promacta/ 2018-05-31T14:09:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/analysis-oncology-pipeline/ 2018-05-31T10:02:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/daiichi-sankyo-develop-new-inflammatory-disease-drugs/ 2018-05-31T10:57:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aptar-propeller-health-partner-digital-medicines-platform/ 2018-05-31T10:48:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-grants-priority-review-astellas-nda-gilteritinib/ 2018-05-31T10:40:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/another-bace1-failure-alzheimers-little-late/ 2018-05-30T14:12:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-biomarins-enzyme-substitution-therapy-treat-pku/ 2022-11-24T12:11:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/gene-therapies-continue-demonstrate-strong-commercial-appeal/ 2018-05-31T10:58:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/allergan-recalls-order-contraceptive-capsules/ 2018-05-30T11:10:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-proposes-adjustment-pharma-intellectual-property-rules/ 2018-05-30T11:01:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-extends-master-services-agreement-beactica/ 2018-05-30T10:43:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/asgct-2018-electroporation-mediated-gene-delivery-coronary-artery-disease/ 2018-05-29T15:02:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/uk-dominates-european-cell-therapy-contract-manufacturing-services/ 2018-05-29T14:58:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/asgct-2018-bringing-cell-gene-therapies-inception-commercialisation/ 2018-05-29T14:47:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alibaba-sell-medical-assets-hong-kong-unit-1-35bn/ 2018-05-29T13:09:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/avara-pharmaceutical-to-buy-novartis-production-plant-canada/ 2018-05-29T13:08:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nih-outlines-roadmap-tackle-alzheimers-disease/ 2018-05-29T11:25:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/can-gene-cell-therapy-revolution-scale/ 2022-03-23T10:35:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/ema-post-brexit-will-uk-become-second-tier-state/ 2018-05-25T15:53:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/asgct-2018-pricing-allow-fair-access-gene-based-therapies/ 2018-05-25T15:30:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/global-biosimilar-market-forecast-reach-99-28bn-2024/ 2018-05-25T14:31:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-decide-tevas-migraine-treatment-september/ 2018-05-25T14:06:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/artificial-intelligence-future-drug-discovery/ 2018-05-25T10:14:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/european-commission-approves-sandozs-biosimilar-zessly/ 2018-05-25T11:13:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-datinvest-shanghai-pharmaceuticals-sunrise-bright-investment/ 2022-07-28T08:10:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/report-pharma-professionals-uk-not-expect-relocation-brexit/ 2018-05-25T11:08:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-cipla-takeda-pharmaceutical-cadila-healthcare/ 2018-05-24T10:37:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-gets-breakthrough-status-fda-cardiomyopathy-drug/ 2018-05-25T11:03:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-claims-chemotherapy-effective-combined-keytruda/ 2018-05-24T15:54:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/esperion-reports-success-study-reduce-ldl-c-levels/ 2018-05-24T15:37:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-technology-focus-issue-71/ 2023-04-12T06:15:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-certifies-new-drug-thrombocytopenia/ 2023-03-23T10:29:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/aimovig-marks-new-milestone-migraine/ 2018-05-24T11:38:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/chinas-enrolment-rate-dips-phase-rises/ 2018-05-24T09:11:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/allergan-buy-aptinyxs-depression-drug-candidate/ 2018-05-24T11:24:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-reviews-sanofis-application-type-1-diabetes-drug/ 2018-05-24T11:34:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-forms-new-alliances-improve-cancer-outcomes/ 2018-05-24T11:01:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-sells-stake-techpool-acquiring-shire/ 2018-05-23T15:38:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/39605/ 2018-05-23T15:18:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/crispr-seismic-shift-gene-editing/ 2018-05-23T13:12:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-congress-approves-right-try-bill/ 2018-05-23T11:32:58+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/fda-companies-generics-manufacturing/ 2018-05-23T09:47:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/evotec-signs-cancer-drug-development-alliance-celgene/ 2018-05-23T09:42:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mit-team-develops-single-injection-polymer-vaccine-polio/ 2018-05-23T09:35:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-sell-chinese-jv-techpool-280m/ 2018-05-23T09:45:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fit-biotech-avacta-announce-positive-results-pilot-affimer-delivery-study/ 2018-05-22T15:40:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-astrazenecas-hyperkalaemia-drug/ 2018-05-22T11:29:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/amgen-seeks-second-chance-imlygic-competitive-melanoma-market/ 2022-03-23T16:06:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/evolving-story-ido-1-inhibitors-fall-grace/ 2023-01-05T06:16:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-european-network-focus-paediatric-medicines/ 2018-05-22T11:20:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-secures-european-approval-new-hiv-1-treatment/ 2018-05-22T09:40:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/harmony-gets-breakthrough-fast-track-status-pitolisant/ 2018-05-22T09:25:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/nevermore-ignore-the-role-of-digital-health-html/ 2021-11-02T03:25:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-fda-evaluate-link-hiv-drug-birth-defects/ 2018-05-21T16:02:05+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/commonwealth-ministers-pledge-combat-ncds/ 2018-05-21T14:37:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/us-worldmeds-lucemyra-may-key-controlling-us-opioid-crisis/ 2018-05-21T10:36:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/new-japanese-flu-treatment-game-changer/ 2018-05-21T10:10:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nohla-series-b-financing/ 2018-05-21T09:58:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/opportunity-abounds-pharma-binge-eating-disorder-marketplace/ 2022-12-12T14:16:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-obtains-us-approval-migraine-drug-aimovig/ 2018-05-21T11:45:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aspirin-combination-therapy-can-reduce-secondary-stroke-risk/ 2018-05-21T11:50:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/short-term-herceptin-use-can-work-specific-breast-cancer/ 2018-05-21T11:22:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-beis-report-calls-pharmaceutical-post-brexit-deal/ 2018-05-18T09:41:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-eli-lilly-fujifilm-holdings-canopy-growth/ 2018-05-21T13:51:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-worldmeds-gets-fda-approval-lucemyra/ 2023-05-10T05:36:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-bolsters-focus-stem-cell-based-therapies/ 2018-05-18T09:23:28+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/deals-week-glaxosmithkline-ligand-catalent-pharma-solutions/ 2018-05-21T14:09:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/ispor-2018-baltimore-html/ 2021-11-02T03:25:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-doctors-proposal-healthcare/ 2018-05-17T16:22:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/fixing-drug-price-crisis-us/ 2018-05-17T15:12:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/roclatan-nda-submission-puts-glaucoma-drug-track-2019-us-launch/ 2022-09-14T11:12:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/kite-netherlands-cell-therapy/ 2018-05-17T08:49:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-closes-8-7bn-acquisition-avexis/ 2018-05-17T11:15:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eiger-expands-lonafarnib-licensing-deal-merck/ 2018-05-17T10:22:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-pfizers-retacrit-biosimilar-treat-anaemia/ 2018-05-17T09:19:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/drug-supply-shortages-in-germany-html/ 2021-11-02T03:26:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-alex-azar-medicare-part-b/ 2018-05-16T16:26:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-drug-results-cluster-headache/ 2018-05-16T08:26:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tapimmune-agrees-merge-marker-therapeutics/ 2018-05-16T13:39:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/danish-researchers-identify-around-100-cancer-targets/ 2018-05-16T11:33:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/beam-receives-gene-editing-technology-licence-harvard/ 2018-05-16T13:34:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/t-cell-biomarkers-show-promise-car-t-therapy-cll-enough/ 2018-05-15T15:49:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/trump-drug-pricing-speech/ 2018-05-15T14:40:39+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/medigene-bluebird-tcr-partnership/ 2018-05-15T09:11:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-novartis-gilenya-treat-paediatric-multiple-sclerosis/ 2018-05-15T10:37:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-buy-canadas-aurka-pharma-110m-upfront/ 2018-05-15T10:44:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/big-data-used-analyse-animal-studies-ability-predict-human-safety/ 2018-05-15T15:37:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-boosts-brain-cancer-research-40m-funding/ 2018-05-15T12:07:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/biotech-ma-will-2018-surge-last/ 2018-05-14T14:14:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/ubrogepant-trial-results-set-secure-allergans-future-migraine-market/ 2022-07-11T08:55:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-president-trump-unveils-plan-lower-prices-drugs/ 2018-05-14T11:12:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-finding-help-predict-cancer-resistance-parp-inhibitors/ 2018-05-14T16:19:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-committee-recommends-akceas-chylomicronemia-drug/ 2018-05-14T10:49:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astra-zeneca-copd-trial-fasenra/ 2018-05-14T13:30:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-tecentriq-fails-trial/ 2018-05-11T15:36:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/astrazeneca-continues-invest-stem-cell-research/ 2018-05-11T14:20:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/abbvies-risankizumab-edges-closer-approval-moderate-severe-psoriasis/ 2018-05-11T14:02:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-seeks-shut-stem-cell/ 2018-05-11T11:56:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/inside-canadas-centre-drug-research-development/ 2018-05-11T10:44:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-armo-biosciences/ 2018-05-11T09:27:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-strides-shasun-takeda-pharmaceutical-eli-lilly/ 2018-05-11T09:23:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-mannkind-xtalpi-ascendia-pharmaceuticals/ 2018-05-11T09:33:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/apotex-strides-combine-australian-new-zealand-businesses/ 2018-05-11T10:39:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vyriad-construct-oncolytic-virus-vaccine-production-facility-us/ 2018-05-11T11:39:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/allen-institute-launches-3d-model-live-human-cell/ 2018-05-11T10:25:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/impact-of-passing-through-rebates-html/ 2021-11-02T03:27:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/cphi-experts-90-current-pipeline-apis-poorly-soluble/ 2018-05-10T10:52:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/cphi-experts-warn-possibility-catastrophic-success-cell-therapy-manufacturing/ 2018-05-10T10:32:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/fda-novartis-thyroid-tafinlar/ 2018-05-10T09:18:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lannett-generic-drugs-endo/ 2018-05-10T08:58:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-announces-eu-approval-lynparza-ovarian-cancer/ 2018-05-10T09:57:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lodo-signs-drug-discovery-deal-genentech/ 2018-05-10T10:29:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/xtalpi-pfizer-develop-ai-software-identify-new-drugs/ 2018-05-10T10:16:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/novartis-payments-cohen-trump/ 2018-05-15T16:26:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/experts-clinical-trial-transparency/ 2022-07-11T08:55:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/unlocking-potential-chinese-medicine/ 2018-05-09T14:51:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/dermatology-pharmas-latest-focus/ 2023-05-19T03:25:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nih-trial-study-kidney-transplants-hiv-patients/ 2018-05-09T09:53:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/shire-agrees-totakedas-46bn-acquisition-offer/ 2018-05-09T16:13:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-janssens-darzalex-treat-multiple-myeloma/ 2018-05-09T09:21:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/esketamine-depression-ketamine/ 2023-03-27T13:26:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/golden-age-cdmo-industry-retrospective-jim-miller/ 2018-05-08T14:39:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/new-fund-will-address-misuse-drugs-uk-care-homes/ 2018-05-14T10:21:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/china-india-import-tariffs/ 2018-05-08T10:20:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genentech-secures-fda-priority-review-status-tecentriq/ 2018-05-08T10:27:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-sell-rights-seroquel-luye-pharma-538m/ 2018-05-08T11:38:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-bidmc-opens-immunotherapy-research-institute/ 2018-05-08T09:56:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/first-quarter-report-teva/ 2018-05-04T15:51:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bristol-myers-squibb-flatiron-rwe/ 2018-05-04T11:09:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/study-mdma-ptsd/ 2018-05-04T10:55:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/gileads-hcv-portfolio-disappoints-amid-pressure-abbvies-mavyret/ 2018-05-04T10:10:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/worlds-first-car-t-therapy-approved-second-indication/ 2018-05-04T09:02:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-forms-alliance-advance-abituzumab-colorectal-cancer/ 2018-05-04T09:43:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-intelgenx-oasmia-pharmaceutical-karo-pharma/ 2018-05-04T10:04:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bavarian-nordics-chordoma-vaccine-secures-orphan-drug-status/ 2021-11-22T06:41:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/2018-april-top-stories-pharma/ 2021-11-24T05:37:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-united-therapeutics-par-formulations-endo-ventures/ 2018-05-04T10:11:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-researchers-develop-new-cure-bone-diseases/ 2018-05-04T10:11:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-fda-approval-kymriah/ 2018-05-03T09:21:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-acquire-benevir-biopharm-1bn/ 2018-05-03T10:42:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-submits-application-ema-psoriasis-drug-approval/ 2018-05-03T14:04:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/researchers-call-alternative-hiv-therapy-approaches/ 2018-05-03T14:12:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/boosting-biosimilar-uptake-us-needs-change/ 2021-07-30T15:56:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/immune-car-t-cell-therapy/ 2018-05-02T13:32:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/positive-chmp-opinion-prolia-label-expansion-will-boost-sales/ 2018-05-02T13:30:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssens-psoriasis-drug-fad-nice/ 2018-05-02T13:07:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/united-therapeutics-purchase-steadymed-216m-deal/ 2018-05-02T10:34:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ironwood-pharmaceuticals-divide-two-companies/ 2018-05-02T10:09:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-gets-us-approval-adjuvant-therapy-treat-melanoma/ 2018-05-02T09:46:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/acadia-shares-fda-investigation/ 2021-12-02T06:38:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/wuxi-biologics-build-e325m-biomanufacturing-facility-ireland/ 2018-05-01T11:39:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/daiichi-sankyo-restructure-vaccines-subsidiary/ 2018-05-01T12:51:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ani-pharma-acquire-assets-amneal-impax/ 2018-05-01T09:48:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-merck-bladder-cancer-keytruda/ 2018-04-30T16:24:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/humira-biosimilars-launch-eu-year-will-uptake-similar-remicade-biosimilars/ 2018-04-30T11:16:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/cured-but-at-what-cost/ 2018-04-30T10:40:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/autism-prevalence-rises-us-children/ 2023-01-23T12:46:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/european-chmp-recommends-gileads-biktarvy-treat-hiv-1/ 2018-04-30T13:18:43+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/bms-forms-collaboration-study-lupus-drug/ 2018-04-30T10:21:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/digital-tech-unlock-billions-savings-pharma-companies/ 2018-04-27T15:27:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/takeda-chases-largest-deal-yet/ 2018-04-27T13:09:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-ctd-holdings-peptron-hemispherx-biopharma/ 2018-04-26T16:31:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-astrazeneca-mega-labs-toho-holdings/ 2018-04-26T16:34:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/report-small-biotech-firms-lead-microbiome-targeted-therapy-space/ 2018-04-27T10:47:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-forms-chinese-alliance-diabetes-care/ 2018-04-27T09:37:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/proteus-digital-health-develops-pipeline-31-digital-drugs/ 2018-04-27T10:34:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/anticholingeric-antidepressants-dementia/ 2018-04-26T16:15:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/celldex-workforce-trial-failure/ 2018-04-26T16:07:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/creates-act-dropped-may-still-see-progress/ 2018-04-26T15:54:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pan-cancer-atlas-will-validate-precision-medicine-approaches/ 2018-04-26T09:54:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-q1-report-fall-earnings/ 2018-04-30T08:55:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/natural-barcode-helps-track-cells-genetic-information/ 2018-04-26T09:55:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/india-teams-world-bank-boost-healthcare-sector/ 2018-04-26T10:23:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nektar-takeda-test-combination-regimen-cancer/ 2018-04-26T09:27:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/research-orphan-drug-europe/ 2018-04-25T16:24:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/tracing-story-mumps-timeline/ 2024-08-21T05:33:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/focusing-user-experience-reinvent-drug-rd-software/ 2018-04-25T13:35:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/world-malaria-day-2018-achieve-eradication-malaria-transmission-must-stopped/ 2018-04-25T10:32:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/world-malaria-day-who/ 2018-04-25T10:26:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/late-stage-type-2-diabetes-pipeline-dominated-drugs/ 2023-03-20T10:40:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/hemlibra-receives-fda-breakthrough-therapy-designation/ 2018-04-24T14:44:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tweaking-diabetes-treatments-can-improve-effectiveness/ 2018-04-25T10:40:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/topas-partners-boehringer-vector-based-drugs/ 2018-04-25T11:10:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/ketamine-may-become-key-therapy-treatment-depression/ 2018-04-24T15:22:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/state-us-somatic-cell-therapy-facilities/ 2018-04-24T13:41:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/new-therapy-set-dominate-hiv-market/ 2018-04-24T12:51:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/tremfya-approval-increasing-options-psoriasis-treatment/ 2018-04-24T12:49:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/blockbuster-immunology-drugs-facing-patent-expiry-biosimilar-competition/ 2018-04-24T10:09:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-offer-shire-takeover/ 2018-04-24T09:14:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogen-ionis-develop-neurological-drugs-1bn-deal/ 2018-04-24T09:54:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizers-trumenba-gets-breakthrough-status-meningococcal-disease/ 2018-04-24T10:20:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/belgiums-ucb-buys-proximagens-epilepsy-drug/ 2018-04-24T10:47:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/fresenius-akorn-deal/ 2018-04-23T16:32:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dea-rules-manufacture-opioids/ 2018-04-23T16:20:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nanomedicine-coating-technique-improves-drug-delivery/ 2018-04-23T15:32:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/experts-call-review-pharma-manufacturing-processes/ 2018-04-23T11:24:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pfizer-funds-creakyjoints-initiative-shared-decision-making-rheumatoid-arthritis/ 2018-04-23T10:48:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/world-immunisation-week-2018-spotlights-remaining-vaccine-coverage-gaps/ 2018-04-23T10:40:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-committee-cbd-epilepsy/ 2018-04-23T08:28:58+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/phrma-report-neurological-drugs/ 2018-04-23T08:19:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pg-buys-mercks-consumer-health-business-4-2bn/ 2021-10-25T09:01:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/queensland-focuses-new-drug-motor-neurone-disease/ 2018-04-23T10:29:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tocagen-licences-cancer-immunotherapy-apollobio/ 2018-04-23T09:57:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/jj-discontinues-development-c-difficile-antibiotic-cadazolid/ 2018-04-20T12:52:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/marijuana-possible-solution-opioid-crisis/ 2018-04-20T09:11:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/sanofis-next-steps-following-nices-rejection-dupixent/ 2018-04-20T08:49:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-clovis-oncology-les-laboratoires-servier-bayer/ 2018-04-20T09:16:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-wacker-biotech-pacific-glory-development-proteintech-group/ 2018-04-20T09:28:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/benevolentai-raises-115m-to-boost-ai-based-drug-development/ 2023-02-23T05:37:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-fda-approves-astrazenecas-tagrisso-for-nsclc/ 2018-04-20T10:41:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/shire-turns-down-takedas-44bn-takeover-bid/ 2018-04-20T09:53:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-ema-regulation-brexit/ 2018-04-19T16:28:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-technology-focus-issue-70/ 2023-04-12T06:25:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/adocia-blood-sugar-technology/ 2018-04-19T10:18:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sempre-health-novo-nordisk-diabetes/ 2018-04-19T09:54:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/can-ai-blockchain-tech-help-bring-drug-prices/ 2023-02-06T07:12:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/novo-nordisk-red-cross-ncds/ 2018-04-19T09:38:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ge-creates-ready-run-factory-viral-vector-drugs/ 2018-04-19T11:47:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sandoz-pear-create-digital-therapeutics-opioid-use-disorders/ 2023-05-10T05:35:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-fast-tracks-roches-hemlibra-haemophilia/ 2018-04-19T11:32:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/us-tariffs-likely-to-mostly-affect-us-generics-makers-html/ 2021-11-02T03:27:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/fda-grants-priority-review-verastems-duvelisib-toxicities-weaken-prospects/ 2018-04-18T10:35:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/anaptysbios-anb-020-remains-strong-potential-contender-peanut-allergy-market/ 2018-04-18T09:28:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/incytes-clinical-trial-flop-indicates-uncertain-future-ido-inhibitors/ 2022-07-11T08:55:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/astrazeneca-cancer-drug-trials-imfinzi/ 2018-04-18T09:01:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-lilly-support-new-chronic-kidney-disease-study/ 2022-12-03T08:46:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mit-researchers-create-artificial-antimicrobial-peptides/ 2018-04-18T10:15:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/advent-talks-buy-sanofis-generics-business-e1-9bn/ 2018-04-18T10:30:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/astrazeneca-deal-shows-promise-molecular-partners-lung-cancer-therapy/ 2018-04-18T09:08:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/canada-drug-fined-counterfeit-drugs/ 2018-04-17T15:45:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/azeliragon-third-alzheimers-failure-2018/ 2023-07-17T13:07:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/su2c-lustgarten-partner-drive-pancreatic-cancer-research/ 2018-04-17T10:47:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-approach-enhances-gene-editing-accuracy/ 2018-04-17T11:29:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-janssen-partner-develop-cardiovascular-therapy/ 2018-04-17T11:41:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-vaccine-manufacturing-ghana/ 2018-12-10T10:17:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mercks-new-collaboration-aims-affordable-vaccines/ 2018-04-16T11:43:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/silenced-immune-cells-can-activated-fight-diseases/ 2018-04-16T11:45:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/shire-divest-oncology-unit-frances-servier-2-4bn/ 2018-04-16T14:17:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/biosimilar-frontrunner-celltrion-lose-first-market-advantage-truxima-us/ 2018-04-13T10:30:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-novartis-roche-alexion/ 2018-04-13T08:51:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-open-e350m-vaccines-facility-canada/ 2018-04-13T09:17:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-forms-new-research-alliance-fibrotic-disease-drugs/ 2018-04-13T10:13:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-mapi-pharma-recordati-mylan/ 2018-04-13T09:00:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-divests-rare-disease-portfolio-orchard-therapeutics/ 2018-04-13T09:54:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/otsuka-takara-co-develop-therapies/ 2018-04-13T10:18:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lonza-gene-therapy-texas/ 2018-04-12T14:22:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/rebiotix-acquisition-solidifies-ferrings-position-microbiome-space/ 2021-09-10T11:52:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/biopharma-industry-safe-us-china-trade-war/ 2018-04-12T10:49:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/new-antibody-screening-method-lead-better-drugs/ 2018-04-12T09:42:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alexion-wilson-therapeutics-855m/ 2018-04-12T12:56:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mylan-gain-rights-mapi-pharmas-multiple-sclerosis-drug/ 2018-04-12T10:40:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-build-new-biomanufacturing-plant-rhode-island-us/ 2018-04-12T10:21:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/symcel-test-calscreener-antibiotic-susceptibility/ 2018-04-12T11:26:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rigel-kidney-disease-drug-trial/ 2018-04-12T13:00:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/study-shows-antiepileptics-enhance-dementia-risk/ 2018-04-11T09:49:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-licences-ionis-nash-drug-candidate/ 2018-04-11T12:36:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-provide-75m-advance-prostate-cancer-treatment/ 2018-04-11T11:29:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/quralis-seed-funding-als-research/ 2018-04-12T13:02:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/results-merck-incyte-cancer-trials-epacadostat/ 2021-10-29T05:21:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-government-dmd-drug-price/ 2023-01-23T13:19:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-rejects-roche-ms-drug-ocrelizumab/ 2018-04-12T13:07:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-researchers-find-40-genes-associated-myeloma/ 2018-04-10T10:15:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-closes-1-9bn-flatiron-health-acquisition/ 2018-04-10T09:59:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/antibiotics-may-treat-drug-resistant-bacterial-infections/ 2018-04-10T10:37:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/long-will-infliximab-biosimilars-dominate-us-anti-tnf-market/ 2018-04-09T12:21:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/johnson-37m-baby-powder-cancer/ 2018-04-09T09:02:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-dndi-develop-visceral-leishmaniasis-therapy/ 2023-06-14T07:02:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-agrees-take-avexis-8-7bn/ 2018-04-09T10:38:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-gets-rights-epidestinys-blood-disease-drug/ 2018-04-09T10:00:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/tetra-granted-fda-orphan-drug-designation-fxs-treatment-will-enough/ 2018-04-06T15:01:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/sunovions-nda-submission-adds-fuel-rivalry-acorda/ 2018-04-06T14:49:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/drug-approval-forecast-highlights-increasing-profits-biktarvy-erleada/ 2018-04-06T11:11:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-lansen-pharmaceutical-fagron-hunan/ 2018-04-05T11:22:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/age-related-macular-degeneration-sales-reach-11-5bn-2026/ 2018-04-06T10:47:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-artificial-enzyme-employs-light-bacteria/ 2018-04-09T09:05:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-twist-bioscience-kangmei-pharmaceutical-daiichi-sankyo/ 2018-04-06T08:42:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-ose-immunotherapeutics-develop-new-cancer-drug/ 2018-04-09T09:06:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-sigilon-collaborate-diabetes/ 2018-04-05T16:26:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/us-drug-pricing-industry-regulate/ 2018-04-05T15:37:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/award-winning-pharma-packaging/ 2018-04-05T15:13:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/microbiome-targeted-immunotherapies-getting-pricing-right/ 2018-04-05T14:36:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/sanofi-got-dance/ 2018-04-05T13:43:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/allergan-phase-iii-results-bipolar-drug/ 2018-04-05T08:22:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/glenmark-signs-deal-helsinns-akynzeo-india-nepal/ 2018-04-05T10:28:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/stanford-university-devises-new-way-make-noscapine-drug/ 2023-05-31T05:24:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/anti-egfr-tnf-combination-may-treat-lung-cancers/ 2018-04-05T10:50:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pg-pfizer-consumer-healthcare-gsk/ 2018-04-05T08:32:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-consumer-healthcare-novartis/ 2018-04-05T08:33:53+00:00 daily 1.0 https://www.pharmaceutical-technology.com/comment/contract-manufacturers-must-fill-capability-gaps-benefit-cell-therapy-approvals/ 2018-04-04T14:59:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/medimmune-signs-license-deal-compugen-antibody-products/ 2018-04-04T10:21:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/allogene-enters-asset-contribution-agreement-pfizers-car-t-drugs/ 2018-04-04T10:08:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-review-sanofis-dupixent-drug-asthma/ 2018-04-04T09:55:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/leukaemia-astrazeneca-license/ 2018-04-09T10:48:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alkermes-refusal-file-depression-drug/ 2018-04-05T08:32:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pfizers-pipeline-specialisation/ 2018-04-03T15:12:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/counter-availability-will-boost-viagra-sales/ 2018-04-03T14:58:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-trial-cardiac-disease-drug/ 2018-04-03T14:48:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-technology-focus-issue-69/ 2023-04-12T06:08:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/geographic-scope-biosimilar-regulatory-pathways-little-late/ 2018-04-03T12:47:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/shooting-future-hold-growth-drugs/ 2018-03-26T15:06:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgens-blincyto-gets-us-approval-acute-lymphoblastic-leukaemia/ 2018-04-03T10:45:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/2018-march-top-stories-pharma/ 2018-04-05T09:29:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-rna-based-therapy-can-potentially-treat-west-nile-virus/ 2018-04-03T12:57:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lung-cancer-drug-crizotinib-may-targeted-breast-cancer-therapy/ 2018-04-03T12:59:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-manufacturing-hotspots/ 2021-11-22T09:34:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-jaguar-health-sichuan-kelun-pharmaceutical-ptc-therapeutics/ 2018-03-29T08:44:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-glaxosmithkline-bal-pharma-novaquest-capital-management/ 2018-03-29T08:55:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-committee-approve-lofexidine-opioid/ 2018-03-29T16:30:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fujifilm-acquires-companies-800m/ 2018-03-29T16:23:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-shire-takeover/ 2018-03-29T16:15:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/regeneron-potential-succeed-despite-lacklustre-share-performance/ 2018-03-29T09:45:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-accepts-bms-sbla-opdivo-yervoy-colorectal-cancer/ 2018-03-29T08:58:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/racemisation-risk-new-tool-identify-drugs-destined-fail/ 2018-03-26T14:45:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-grants-breakthrough-therapy-designation-fennecs-pedmark/ 2018-03-29T13:58:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/daiichi-sankyo-partners-research-new-cancer-therapy/ 2018-03-29T11:08:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/protagonistsphase-iib-ulcerative-colitis/ 2018-03-28T16:22:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mercks-tepotinib-fast-track-japan/ 2018-03-28T15:54:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-flu-vaccine/ 2018-03-28T15:43:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/roches-tecentriq-avastin-may-upper-hand-renal-cancer/ 2018-03-28T13:21:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pricing-adjustments-car-t-therapies-likely-2018-beyond/ 2018-03-28T12:58:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/step-towards-earlier-detection-parkinsons-disease/ 2023-01-30T15:54:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-androgel-lawsuit-testosterone/ 2018-03-28T09:31:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/seamless-trials-key-drug-approvals/ 2022-07-11T08:55:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tracelink-finds-disparity-pharma-industry-serialisation-targets/ 2018-03-28T11:35:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/virtual-tumour-model-improve-targeted-cancer-treatment/ 2018-03-28T10:10:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uvas-new-trial-aims-help-lung-transplant-recipients/ 2018-03-28T10:42:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/global-osteoporosis-market-reach-11-2bn-2027/ 2023-05-15T03:54:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/gsk-enlists-retail-pharmacies-hasten-us-uptake-shingrix/ 2018-03-27T15:28:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/first-big-pharma-company-distribute-medical-cannabis-products/ 2018-03-27T14:14:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/rituximab-biosimilars-hype-warranted/ 2018-03-27T10:24:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-ablynx-lupus-phase-ii-trial/ 2022-07-11T08:55:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/legitimising-stem-cell-therapies-path-fda-approval/ 2018-03-27T09:57:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/turning-heat-nano-research/ 2018-03-26T14:30:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-acquire-novartis-stake-healthcare-jv-13bn/ 2018-03-27T09:59:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/canadian-study-finds-daily-ibuprofen-can-prevent-alzheimers/ 2018-03-27T11:53:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-viivs-juluca-gets-chmp-recommendation-hiv-1/ 2018-03-27T10:41:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/the-economic-impact-of-diagnosed-diabetes-html/ 2021-11-02T03:27:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eu-allogenic-crohns-alofisel/ 2018-03-26T15:01:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/fdas-biosimilars-push-will-interchangeability-requirements-change/ 2018-03-26T10:44:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/riding-nektars-wave-cytokine-immunotherapies-oncology/ 2018-03-26T09:45:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-pulls-out-of-20bn-auction-of-pfizer-consumer-healthcare/ 2018-04-04T11:21:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-phase-iii-ms-siponimod/ 2018-03-26T09:05:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/augusta-university-develops-new-chimera-molecule-breast-cancer/ 2018-03-26T10:27:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eisai-merck-get-japanese-regulatory-approval-lenvima/ 2018-03-26T12:10:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/european-chmp-recommends-sandozs-biosimilar-infliximab/ 2018-03-26T10:45:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/barricading-front-door-colombias-moves-toward-valuebased-pricing-html/ 2021-11-02T03:27:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-tasigna-gets-approval-for-rare-leukaemia-in-us-children/ 2018-03-23T12:05:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/japans-shionogi-signs-carb-x-partnership-to-tackle-cre-superbug/ 2018-03-23T12:10:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/study-finds-about-60-of-drug-safety-experts-prefer-ai/ 2018-03-26T11:27:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-vistin-pharma-shenzhen-neptunus-bioengineering/ 2018-03-23T08:54:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-otsuka-pharmaceutical-factory-shin-kowa-pharmaceutical/ 2018-03-23T09:15:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/akceas-fcs-drug/ 2023-01-04T11:15:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mps-cystic-fibrosis-orkambi-nhs/ 2018-03-22T17:07:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/block-lock-functional-cure-hiv/ 2018-03-22T11:40:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/croi-2018-early-stage-rd-sets-guideposts-future-cmv-therapies/ 2021-11-22T14:32:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tcr2-125m-funding-t-cell/ 2018-03-22T10:04:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/regeneron-alnylam-find-new-rnai-drugs-nash-disease/ 2018-03-22T11:43:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/helsinn-purchase-skin-cancer-drug-valchlor-actelion/ 2018-03-22T10:36:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-forms-new-partnership-better-study-multiple-myeloma/ 2018-03-22T12:08:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-rejects-dompes-drug-cenegermin/ 2018-03-21T17:08:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pfizers-rituximab-biosimilar-edges-closer-approval/ 2018-03-21T11:34:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/thermo-fisher-job-cuts-brexit/ 2018-03-21T09:36:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-joins-efforts-to-develop-new-medical-treatments/ 2018-03-21T11:49:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-expands-lymphoma-indications-for-seattle-genetics-adcetris/ 2018-03-21T16:14:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/prothena-partners-with-celgene-for-new-neurodegenerative-therapies/ 2018-03-21T16:18:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-obesity-semaglutide-trial/ 2022-07-11T08:56:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nhs-pharmacists-care-homes/ 2018-03-21T11:03:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pistoia-alliance-calls-life-sciences-firms-support-lab-future/ 2018-03-20T12:25:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tilray-partners-sandoz-canada-develop-medical-cannabis-products/ 2018-03-20T12:44:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizers-snda-xtandi-gets-priority-review-prostate-cancer/ 2018-03-20T12:34:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abivax-2017-report-hiv-research/ 2018-03-19T16:23:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/hope-horizon-obesity-market/ 2018-03-20T14:36:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/thermo-fisher-invest-new-pharma-services-facility-germany/ 2018-03-19T12:39:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/merck-positions-keytruda-success-bladder-cancer-space/ 2018-03-19T11:38:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/digital-health-new-direction-neurology/ 2023-03-03T11:22:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cytoreason-ai-anti-inflammatories/ 2018-03-19T09:30:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bavarian-nordic-develop-vaccine-equine-encephalitis/ 2018-03-19T11:35:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lundbeck-buy-netherlands-prexton-therapeutics-e905m/ 2018-03-19T16:46:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/auris-tinnitus-treatment-fails-trial/ 2022-07-11T08:56:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cfda-reform/ 2018-03-21T11:02:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-supernus-pharmaceuticals-vanda-pharmaceuticals-intellipharmaceutics-international/ 2018-03-16T09:55:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nih-funded-trials-h7n9-influenza-vaccine-begin-enrolment-us/ 2018-03-16T11:12:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ionis-akcea-enter-licensing-deal-two-rare-disease-drugs/ 2018-03-16T12:56:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-seattle-genetics-gryphon-investors-chryscapital/ 2018-03-16T10:01:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssens-urothelial-cancer-drug-gets-breakthrough-therapy-designation/ 2018-03-16T12:46:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/2018-year-making-strategic-alliances-dmd/ 2018-03-15T11:23:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/advaxis-trial-death/ 2023-01-04T11:33:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ono-pharma-merus-sign-licence-deal-bispecific-antibody/ 2018-03-15T16:39:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/canadian-us-scientists-partner-fight-brain-diseases/ 2018-03-15T11:46:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/certara-forms-consortium-immuno-oncology-simulation/ 2018-03-15T12:25:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/right-to-try-bill-house-approval/ 2018-03-16T11:19:22+00:00 daily 1.0 https://www.pharmaceutical-technology.com/comment/blockbuster-oncology-deal-merck-eisai/ 2018-03-14T13:34:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abcellera-develop-response-platform-viral-pandemics/ 2018-03-14T11:51:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringers-new-project-vanderbilt-targets-cancer/ 2018-03-14T12:31:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/anti-cancer-drug-may-reverse-social-deficits-associated-autism/ 2022-12-20T10:15:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/risksharing-as-a-path-forward-for-mexico-html/ 2021-11-02T03:27:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/addiction-gene-kifc1-breast-cancer/ 2018-03-13T16:53:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ritter-data-lactose-intolerance-trial/ 2022-07-11T08:56:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vbl-halts-phase-iii-rgbm-trial/ 2018-03-13T12:52:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/universal-flu-vaccine-horizon/ 2018-03-13T11:30:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/taimeds-trogarza-large-impact-hiv-treatment/ 2018-03-23T15:04:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tae-technologies-forms-life-sciences-subsidiary/ 2023-08-08T04:57:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sarepta-therapeutics-seek-fda-approval-golodirsen/ 2018-03-13T10:50:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/glp-1-agonists-sglt-2-inhibitors-sales-surpassed-8bn-2017/ 2018-03-13T11:49:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogen-pfizer-schizophrenia-590m/ 2018-03-12T17:32:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ai-atomwise-45m-drug-research-technology/ 2018-03-12T12:20:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/seattle-genetics-concludes-cascadian-therapeutics-acquisition/ 2018-03-12T11:40:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/labcorps-covance-forms-new-biologic-drug-development-unit/ 2018-03-12T11:11:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/researchers-in-belgium-identify-new-antifungal-compounds/ 2022-03-25T07:49:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cigna-express-scripts-67-billion/ 2018-03-12T12:08:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/non-opioid-better-opioids-chronic-pain/ 2018-03-09T14:23:58+00:00 daily 1.0 https://www.pharmaceutical-technology.com/comment/potential-drug-repurposing-orphan-drug-development/ 2018-03-09T13:26:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/can-big-data-improve-diagnosis-rare-diseases/ 2018-03-09T11:00:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-talks-evotec-anti-infectives-rd-platform/ 2018-03-09T16:18:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/prevail-therapeutics-gets-funding-support-gene-therapies/ 2018-03-09T10:10:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-mas-week-zydus-cadila-healthcare-eisai-tabuk-pharmaceuticals-manufacturing-company/ 2018-03-09T10:06:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-study-finds-il-7-can-boost-immunity-sepsis/ 2018-03-09T15:59:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-fda-approval-dengvaxia/ 2018-03-08T17:21:27+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/pfizer-swansea-university-innovation-hub/ 2018-03-08T14:15:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/researchers-combine-immunotherapy-hydrogel-treat-cancer/ 2018-03-08T11:36:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cepi-awards-funding-themis-lassa-fever-mers-vaccines/ 2022-12-02T14:42:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eisai-merck-partner-develop-sell-cancer-drug-lenvima/ 2018-03-08T12:23:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/starving-bacteria-iron-amr/ 2018-03-07T17:12:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cantrell-restraining-order-fda/ 2018-03-07T16:09:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pharma-firms-investing-cyber-security/ 2018-06-21T14:31:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/ms-drug-zinbryta-withdrawn-deadly-safety-issues-reported/ 2018-03-07T10:13:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/celgene-completes-9bn-juno-therapeutics-acquisition/ 2018-03-07T17:45:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-taimeds-trogarzo-treat-hiv/ 2018-03-07T11:06:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nih-trial-finds-short-term-tuberculosis-therapy-effective/ 2018-03-07T17:31:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-study-hiv-art/ 2018-03-07T10:16:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/cracking-mysteries-alzheimers-disease/ 2018-03-06T15:27:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/homology-100-million-ipo/ 2018-03-09T16:49:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-accepts-sanofis-sbla-dupixent-asthma/ 2023-05-30T04:27:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vividion-celgene-sign-drug-discovery-deal/ 2018-03-06T10:49:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/crispr-identifies-possible-drug-targets-als/ 2018-03-06T17:29:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/february-2018-top-news-stories-pharma/ 2018-03-06T17:26:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/theresa-may-ema-brexit/ 2018-03-06T09:31:36+00:00 daily 1.0 https://www.pharmaceutical-technology.com/comment/2017-tipping-point-oncology-biosimilar-space/ 2018-03-05T11:08:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rubius-rcts/ 2018-03-05T09:30:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-researchers-invent-immunotherapy-y-traps-fight-cancer/ 2018-03-05T11:51:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogen-abbvie-voluntarily-withdraw-zinbryta-authorisations/ 2018-03-05T12:13:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-agreement-accelerate-drug-rd-uk/ 2018-03-05T12:39:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-sorrento-painkiller-patch/ 2018-03-05T10:35:35+00:00 daily 1.0 https://www.pharmaceutical-technology.com/comment/biopharma-financing-showed-healthy-growth-january/ 2018-03-02T11:19:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-pear-digital-therapeutics-apps/ 2018-03-02T10:17:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-sms-lifesciences-india-merck-teijin/ 2018-03-02T16:18:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-pfizer-n4-pharma-tesaro/ 2018-03-01T13:20:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-partners-pear-therapeutics-develop-digital-therapies/ 2018-03-07T14:30:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/second-genome-forms-four-new-alliances-immuno-oncology-rd/ 2018-03-02T16:35:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/report-ckd-induced-comorbidity-drug-market-witness-9-5-cagr/ 2018-03-02T12:45:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cost-effectivity-mengitis-vaccines/ 2023-03-31T10:42:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/eus-falsified-medicines-directive-set-bring-scheduling-burdens-manufacturers/ 2018-03-01T13:54:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/increasing-dose-outsourcing-masks-long-term-concerns/ 2018-03-01T13:43:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/moderate-growth-multiple-sclerosis-market/ 2018-03-01T11:16:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/poor-seasonal-influenza-efficacy-necessitates-shift-away-egg-based-manufacturing/ 2018-03-01T10:59:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/celgene-ms-drug-rejected-fda/ 2018-03-01T10:09:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/beigenes-revlimid-receives-chinese-approval-multiple-myeloma/ 2018-03-01T12:09:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mylan-revance-develop-market-botox-biosimilar/ 2018-03-01T12:13:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/study-finds-20-prescribed-antibiotics-england-inappropriate/ 2018-03-01T13:30:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/gsk-dynavax-clear-winners-2017-vaccines-space/ 2018-02-28T19:58:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astra-zeneca-autoimmune-spinout/ 2018-03-01T09:40:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/proposed-fda-budget-increase-boost-continuous-manufacturing-approvals/ 2018-02-28T11:49:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/biosimilars-celltrion-paves-way-herceptin-copycats-2018/ 2018-02-28T11:24:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/protein-cancer-drug-resistance/ 2018-03-01T09:42:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-lillys-verzenio-advanced-breast-cancer/ 2018-02-28T10:37:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/precision-therapeutics-forms-new-tumorgenesis-subsidiary/ 2018-02-28T12:10:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-forms-drug-research-alliance-aldeyra-therapeutics/ 2018-02-28T10:55:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/on-the-road-to-hta-harmonization-in-europe-html/ 2021-11-02T03:27:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/pfizer-owe-nhs-5m/ 2018-02-27T17:28:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-kempharm-opioid-apadaz/ 2018-02-27T16:01:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/fentanyl-go-wrong/ 2024-07-23T11:25:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/kite-sangamo-partnership-bucks-trend-crispr-based-cancer-therapeutics/ 2018-02-27T10:46:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/mercks-viralytics-deal-reinforces-keytruda-centric-oncology-franchise/ 2018-02-27T10:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/most-read/pharma-technology-focus-issue-68/ 2023-04-12T06:47:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nih-joins-efforts-address-two-common-bacterial-infections/ 2023-01-19T06:23:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/elsevier-beijing-university-expand-chinese-medicine-database/ 2018-02-27T10:47:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/acg-joins-applied-dna-prevent-capsule-counterfeiting/ 2018-02-27T11:49:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pcsk9-inhibitors-grew-steadily-dyslipidemia-market-last-year/ 2023-07-07T04:13:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/uks-largest-pharma-companies-oppose-leaving-customs-union/ 2018-02-26T11:13:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lynparza-tablets-get-positive-chmp-opinion-ovarian-cancer/ 2018-02-26T11:09:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-announces-45m-funding-brain-tumour-research/ 2018-02-26T11:16:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/swiss-researchers-study-new-il-18-inhibitor-stills-disease/ 2018-02-26T11:54:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mini-tumour-test-cancer/ 2018-02-23T16:43:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eisai-breast-cancer-drug-nice/ 2018-02-26T09:45:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/trial-tracker-data-unpublished/ 2018-03-05T10:45:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-creso-pharma-mundipharma-roche/ 2018-02-22T14:46:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-n4-pharma-segulah-venture-allergan/ 2018-02-23T10:04:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/benevolentai-buys-research-facility-support-drug-development/ 2018-02-23T10:27:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kite-sangamo-develop-new-cell-therapies-cancer/ 2018-02-23T12:26:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/report-forecast-sees-rise-need-supportive-cancer-care/ 2018-02-23T12:50:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/atrazeneca-antisense-deal-ionis/ 2018-02-22T17:20:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/gilead-led-global-infectious-diseases-space-2017/ 2018-11-19T14:53:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/aad-2018-strong-phase-iib-results-upadacitinib-atopic-dermatitis/ 2018-02-22T11:05:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/will-amazon-new-face-healthcare/ 2018-02-22T10:55:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-acquire-australias-viralytics-394m/ 2018-02-22T09:56:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oric-pharma-advance-oric-101-treatment-resistant-cancers/ 2018-02-22T10:13:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-wave-life-sciences-develop-neurological-treatments/ 2018-02-22T10:26:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/organ-chip-partnership-roche-takeda/ 2018-02-21T17:11:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/blood-test-detect-autism/ 2018-02-28T17:07:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/ophthalmology-biosimilars-market-still-infancy/ 2018-02-21T11:49:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/aad-2018-tremfya-cost-effective-cosentyx-taltz/ 2018-02-21T11:47:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/biogen-continues-dominate-neurology-market/ 2018-02-21T11:18:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/aad-2018-abbvies-risankizumab-boasts-strong-phase-iii-data-psoriasis/ 2018-02-21T09:46:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-voyager-target-one-time-treatment-alzheimers/ 2018-02-21T11:30:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/zealand-pharma-uniquest-develop-new-peptide-therapeutics/ 2021-11-22T08:55:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-study-finds-genetic-cause-behind-drug-resistant-typhoid-strain/ 2018-02-21T12:32:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/small-pharma-steals-spotlight-2017-antibiotics-space/ 2018-02-20T16:14:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gileads-patent-merck-overturned/ 2018-02-20T12:04:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-researchers-make-new-discoveries-brain-health/ 2018-02-20T09:42:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/arix-bioscience-fosun-partner-develop-new-clinical-therapies/ 2018-02-20T12:20:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hansa-medicals-ides-obtains-fda-orphan-drug-status/ 2018-02-20T09:55:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/defines-counter-drug/ 2020-01-31T13:48:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-astrazeneca-imfinzi/ 2018-02-20T14:35:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nhs-cutbacks-clinical-trials/ 2018-02-20T14:52:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/biosimilars-past-future-deals/ 2018-02-19T11:39:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oxford-biomedica-bioverativ-enter-100m-gene-therapy-deal/ 2018-02-19T10:19:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teva-introduces-qvar-redihaler-inhalation-aerosol-us/ 2018-02-19T10:30:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/researchers-develop-new-stem-cell-based-stroke-treatment/ 2018-02-19T13:02:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/anticoagulants-drive-market-growth-multiple-cardiovascular-disease/ 2023-01-19T06:06:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/eylea-drives-sales-top-ophthalmology-players-2017/ 2018-02-16T15:02:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-approves-thyroid-lenvima/ 2018-02-16T11:24:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/lupin-launches-us-tamiflu-generic-amid-worst-flu-season-recent-memory/ 2018-02-16T10:43:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/top-players-cardiovascular-disease-2017/ 2018-02-16T10:13:48+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/novartis-forms-alliance-develop-diarrheal-disease-drug/ 2023-01-05T05:15:00+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/mas-week-astellas-pharma-shenzhen-neptunus-bioengineering-mallinckrodt/ 2018-02-16T09:45:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/report-melanoma-sales-reach-5-5bn-2026/ 2018-02-16T13:15:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-take-flatiron-health-1-9bn/ 2018-02-16T11:10:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-sichuan-languang-development-avadel-pharmaceuticals-cerecor/ 2018-02-16T12:27:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/machine-learning-technology-predicts-outcomes-chemical-reactions/ 2018-02-15T17:20:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-halts-alzheimers-trial/ 2022-12-02T14:45:23+00:00 daily 1.0 https://www.pharmaceutical-technology.com/comment/top-players-metabolic-disorders-2017/ 2018-02-15T14:22:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/trumps-budget-fda-generics-market/ 2018-02-15T12:32:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/using-mrna-target-tumours/ 2018-02-15T11:00:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/two-pipeline-drugs-added-alzheimers-graveyard-2017/ 2018-02-15T10:45:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mallinckrodt-concludes-sucampo-pharma-acquisition-1-2bn/ 2018-02-15T10:31:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-researchers-discover-new-antibiotics-family-soil/ 2018-02-15T14:13:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/curevac-develop-mrna-vaccines-influenza-malaria/ 2018-02-15T10:38:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/bms-signs-3-6bn-deal-nektar-amid-changing-pd-1-pd-l1-landscape/ 2018-02-14T18:44:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/killer-cells-car-t-cancer-therapy/ 2018-02-23T09:25:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-production-method-see-widespread-use-biorenewables/ 2018-02-14T11:11:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-research-finds-living-artificial-tissue-repair-nerve-damage/ 2018-02-14T14:22:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-rejects-biomarins-rare-genetic-disorder-drug/ 2023-03-23T11:07:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/charles-river-laboratories-buy-mpi-research-800m/ 2018-02-14T11:23:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/trial-spondylitis-drug-results/ 2022-07-11T08:56:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pharma-must-juggle-roi-social-concerns-tackle-tropical-diseases/ 2018-02-13T16:13:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/purdue-opioid-marketing/ 2018-02-20T14:44:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/will-us-tax-reform-initiate-next-wave-pharma-ma/ 2018-02-13T11:54:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/multidrug-resistant-cancer-treatment/ 2018-02-13T10:56:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/adc-bio-develops-new-method-produce-antibody-drug-conjugates/ 2018-02-13T11:04:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/seattle-genetics-pieris-pharma-enter-immuno-oncology-alliance/ 2018-02-13T12:47:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pci-pharma-services-intends-buy-australias-pharma-packaging-firm/ 2018-02-13T14:52:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-generics-guidances/ 2018-02-12T17:18:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/cost-control-drug-pricing-policies-around-world/ 2024-07-23T11:25:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/gilead-viivs-hiv-rivalry-heats-biktarvy-approval/ 2018-02-12T15:09:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/despite-generic-erosion-major-product-gsk-maintains-strong-portfolio-respiratory-therapies/ 2018-11-19T14:52:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-focus-schizophrenia-therapies-development/ 2018-02-12T10:12:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-introduces-rebinyn-haemophilia-b-patients-us/ 2018-02-12T12:07:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-study-finds-far-uvc-light-can-kill-airborne-flu-virus/ 2018-02-12T15:09:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/delays-drug-approval-problems-teva/ 2018-02-09T16:56:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-gilead-hiv-patent-infringement/ 2018-02-09T16:43:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deliv-rx-offers-day-prescription-medicine-delivery/ 2018-02-09T13:54:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/biosimilar-threat-hangs-roches-oncology-portfolio/ 2018-02-09T11:23:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-optibiotix-health-cti-biopharma-novabay-pharmaceuticals/ 2018-02-09T10:23:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-zealand-researchers-develop-natural-remedy-diabetes/ 2018-02-09T10:11:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-fujifilm-develop-regenerative-medicine-therapies/ 2018-02-09T10:51:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/report-global-glaucoma-market-set-worth-3-8bn-2026/ 2018-02-09T10:29:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/brilinta-cardiac-events-heart-attack/ 2018-11-26T10:13:04+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/adocia-200m-damages-eli-lilly-partnership/ 2018-02-08T11:57:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/faecal-pills-next-cure-deadly-bowel-infections/ 2018-02-08T10:58:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chinas-dl-medicine-forms-research-alliance-pfizer/ 2018-02-08T11:14:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-obtains-second-fda-breakthrough-tag-meningitis-b-vaccine/ 2018-02-08T11:48:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-enters-drug-development-deal-theravance-biopharma/ 2018-02-08T11:21:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/innovation-prevent-return-pre-antibiotic-era/ 2018-02-07T16:55:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pill-alternative-injections-diabetes/ 2018-02-07T14:19:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-report-reveals-fewer-asthma-attacks-us-children/ 2018-02-07T12:12:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cancer-research-uk-study-anti-cancer-properties-aspirin/ 2018-02-07T10:59:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uks-icr-finds-new-combination-therapy-colon-cancer/ 2018-02-07T11:10:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/immune-checkpoint-inhibitors-dominate-cancer-immunotherapy-landscape/ 2018-02-06T15:18:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-agreement-collaboration-china/ 2018-02-06T15:08:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-sued-vaccine-death-philippines/ 2018-02-06T16:31:39+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/paige-ai-raises-25m-advance-cancer-diagnosis-treatment/ 2018-02-06T10:15:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-scientists-develop-new-hiv-vaccine-production-method/ 2022-12-02T14:27:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mncs-producing-unapproved-antibiotics-india-finds-new-uk-study/ 2018-02-06T10:26:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/world-cancer-day-2018-hold-cancer-research-treatment/ 2018-02-05T17:12:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/challenges-facing-european-contract-manufacturing-organizations/ 2018-02-05T13:13:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-breast-cancer-drug-nhs-england/ 2018-02-06T17:06:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/blockbuster-status-competition-intensifying-parp-inhibitors/ 2018-02-05T11:26:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-states-penalise-japanese-drug-firm-anti-competitive-tactics/ 2018-02-05T09:56:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/danish-researchers-create-new-approach-make-qr-coded-medicines/ 2018-02-05T12:02:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bcrf-us-expands-research-breast-cancer-treatment/ 2018-02-05T10:03:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nasal-spray-could-lower-risk-of-opioid-addiction/ 2018-02-02T16:52:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/biosimilars-surge-cmos-left-cold/ 2018-02-02T10:24:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alkermes-submits-nda-usfda-alks-5461-major-depressive-disorder/ 2018-02-04T16:42:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-sichuan-kelun-pharmaceutical-syros-pharmaceuticals-cerus/ 2018-02-02T09:51:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teva-concludes-703m-womens-health-products-deal-cvc-capital/ 2018-02-02T11:49:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/elsevier-adds-six-start-ups-pharma-innovation-hub/ 2018-02-02T10:36:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-guanhao-biotech-sanofi-grifols-shared-services-north-america/ 2018-02-02T10:00:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amazon-alliance-healthcare-costs/ 2018-02-01T17:18:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/corporate-heavyweights-tackle-healthcare/ 2018-02-01T16:13:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/urgent-action-needed-address-economic-challenges-facing-amr-rd/ 2018-02-01T13:06:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/explosive-biotech-ma-activity-early-2018/ 2018-02-01T12:02:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/sanofis-woes-dengue-continue-opening-door-rival-takeda/ 2018-02-01T11:18:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nih-launches-partnership-to-advance-parkinsons-disease-treatment/ 2018-02-01T09:44:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/seattle-genetics-buy-cascadian-therapeutics-614m/ 2018-02-01T11:13:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/shire-develop-ab-biosciences-platform-autoimmune-diseases/ 2018-02-01T11:17:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-biobank-offers-images-6000-subjects-medical-research/ 2023-02-23T05:37:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/novartis-commercialise-sparks-new-ophthalmology-gene-therapy/ 2018-01-31T16:40:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/roche-makes-headway-year-corporate-deals/ 2018-02-01T10:54:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/biogen-looks-boosts-pipeline-portfolio-following-record-revenue-reports/ 2018-01-31T14:56:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-canadian-initiative-reduce-generic-drug-prices/ 2018-01-31T11:13:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/su2c-us-launches-ai-based-immunotherapy-research-programme/ 2018-01-31T11:17:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/irish-researchers-say-new-technology-can-transform-pharma-market/ 2018-01-31T11:35:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/move-amsterdam-biggest-challenge-ema-ever-deal/ 2018-01-30T17:23:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/e-commerce-companies-allowed-sell-medicine/ 2018-01-30T14:23:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/slipper-limpet-slime-biotech-treasure-chest/ 2018-01-24T15:03:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/brexit-may-disrupt-medicines-supply-warns-british-alliance/ 2018-01-30T11:07:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roches-balovaptan-obtains-fda-breakthrough-therapy-designation/ 2023-01-19T05:43:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ablynx-enters-e3-9bn-acquisition-deal-sanofi/ 2018-01-30T11:12:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/developing-irresistible-cancer-treatments-can-done/ 2018-01-24T14:55:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-pharma-rd-pipeline-strongest-europe/ 2018-01-26T16:26:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-forms-alliance-otc-medicines-maker-unipharm/ 2018-01-29T10:56:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-lutathera-neuroendocrine-tumours/ 2018-01-29T10:42:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-pharma-lobbying-spend-surged-25-4m-2017/ 2018-01-26T12:12:01+00:00 daily 8.0 https://www.pharmaceutical-technology.com/comment/type-2-diabetes-drugs-headed-us-market-2018/ 2018-01-26T11:26:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/vbi-vaccines-pursues-future-hepatitis-b-vaccine-showdown-dynavax/ 2018-01-26T11:08:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/women-likely-develop-dry-eye-men/ 2023-05-23T03:55:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-shenzhen-salubris-pharmaceuticals-usv-sanofi/ 2018-01-25T12:01:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-torrent-pharmaceuticals-medico-remedies-shanghai-pharmaceutical/ 2018-01-25T12:06:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/synthons-syd985-fast-tracked-metastatic-breast-cancer/ 2018-01-26T10:16:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/amgen-novartis-edge-front-migraine-market/ 2018-01-25T15:40:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/court-ruling-crushes-jjs-hopes-zytigas-us-growth/ 2018-01-25T15:15:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-study-investigate-treatment-hiv-pregnant-women/ 2018-01-25T13:47:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-novartis-accused-anti-competitive-conduct-eu-court/ 2018-01-26T10:23:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/dundee-university-visiting-worlds-influential-pharmaceutical-research-institution/ 2018-01-24T14:38:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cardiome-pharma-receives-extended-indications-aggrastat-china/ 2018-01-25T10:15:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astellas-pharma-concludes-225m-mitobridge-acquisition/ 2018-01-25T10:19:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-technology-focus-issue-67/ 2023-04-12T06:05:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/beheard-rewarding-rare-disease-research/ 2018-01-24T14:33:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-transparency-clinical-trials/ 2022-07-11T08:56:27+00:00 daily 1.0 https://www.pharmaceutical-technology.com/comment/celgene-bets-heavily-car-t-revlimid-patent-looms/ 2018-01-24T11:02:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/oncology-digital-medicine-advances-2017/ 2018-01-24T10:59:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/time-europe-embrace-quadrivalent-influenza-vaccine/ 2018-01-25T14:18:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/hiv-generic-developing-world/ 2018-01-24T10:55:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biocryst-idera-sign-merger-agreement-rare-disease-drugs/ 2023-05-09T07:23:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/european-commission-authorises-adcetris-t-cell-lymphoma/ 2018-01-24T10:17:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/beating-polio-public-health-success-story/ 2018-01-23T16:42:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/ai-robot-helps-discover-ingredient-anti-malarial-drug/ 2021-10-25T12:57:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/epilepsy-drug-sales-expected-drop-cagr-7-1/ 2018-01-23T15:16:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/use-parp-inhibitors-breast-cancer-will-vary-based-disease-subtype/ 2018-01-23T15:05:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/treatment-melanoma-approved-european/ 2023-02-03T08:55:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/shires-breakthrough-therapy-maribavir-potential-shake-cytomegalovirus-market/ 2018-01-23T12:12:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/hospital-owned-generics-boon-cmos-2/ 2018-01-23T10:18:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/celgene-signs-9bn-acquisition-deal-juno-therapeutics/ 2018-01-23T10:06:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-offer-funding-new-medicine-manufacturing-centres/ 2018-01-23T10:11:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/biologics-biosimilars-nhs-move-makes-big-sense/ 2018-01-19T15:28:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-acquires-bioverativ-for-11-6bn/ 2018-01-26T10:43:34+00:00 daily 1.0 https://www.pharmaceutical-technology.com/comment/not-profit-hospitals-us-teaming-create-cheap-generic-drugs/ 2018-01-22T10:14:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-agrees-buy-bioverativ-11-6bn/ 2018-01-22T10:04:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-allergan-obtain-marketing-permit-mvasi-europe/ 2018-01-22T10:09:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/partnership-develop-haemophilia-gene-therapy/ 2018-01-22T16:13:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-expres2ion-biotech-holding-arbutus-biopharma-intrexon/ 2018-01-18T12:28:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-kymriah-wins-fast-review-dlbcl-us-europe/ 2018-01-19T09:32:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-approves-daratumumab-use-nhs-myeloma/ 2018-01-19T09:42:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/structure-of-anti-ageing-hormone-discovered/ 2018-01-25T13:59:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/breaking-cancers-drug-addiction/ 2018-01-18T11:28:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringers-gilotrif-receives-approval-egfr-mutation-positive-nsclc/ 2018-01-18T11:45:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-develop-oncology-drugs-cancer-research-uk-icr/ 2018-01-18T11:56:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-drug-regulation-brexit/ 2018-01-25T14:01:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/sanofi-regenerons-kevzara-faces-competition-rheumatoid-arthritis-market/ 2018-01-17T16:58:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/batavia-biosciences-joins-project-develop-new-polio-vaccine/ 2018-01-25T14:03:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sun-pharma-ironwood-allergan-settle-linzess-patent-litigation/ 2021-10-27T12:29:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fdas-mini-sentinel-finds-no-new-concerns-janssens-xarelto/ 2018-01-17T12:09:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-accepts-sandozs-bla-biosimilar-adalimumab/ 2018-01-17T11:22:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/opioid-meds-no-longer-labelled-suitable-children/ 2023-05-31T05:25:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-lynparza-treat-inherited-breast-cancer/ 2023-01-04T12:29:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/helsinn-obtains-orphan-designation-pracinostat-treat-aml/ 2018-01-16T11:00:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/shires-haemophilia-drug-secures-eu-marketing-authorisation/ 2018-01-16T15:09:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/treating-heart-diseases-anti-inflammatories-biggest-breakthrough-since-statins/ 2018-01-15T17:31:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/targeted-therapeutics-made-possible-development-computer-logic-controlled-biomaterials/ 2018-01-16T09:38:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/dupixent-establishing-premier-dermatology-treatment/ 2018-01-15T12:45:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nanobiotix-conduct-pancreatic-cancer-research-nbtxr3/ 2018-01-15T10:21:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eisai-builds-new-oral-solid-dose-production-facility-china/ 2018-01-15T10:31:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pfizer-boosts-uc-presence-approval-second-remicade-biosimilar/ 2018-01-12T13:05:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/epilepsy-drug-sales-hit-7-5bn-2026/ 2018-01-12T11:02:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/billion-dollar-deals-mean-bright-future-takeda/ 2018-01-12T10:24:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/european-commission-approves-astrazenecas-fasenra-asthma/ 2018-01-12T10:31:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-cspc-nbp-pharmaceutical-international-finance-corporation-sun-pharmaceutical/ 2018-01-12T10:05:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-melinta-therapeutics-cipher-pharmaceuticals-baxter-international/ 2018-01-12T10:13:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/japans-heptares-joins-imperial-college-london-drug-rd/ 2018-01-12T10:40:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/texas-research-finds-new-way-improve-brain-cancer-therapy/ 2018-01-12T11:54:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/easy-swallow-rapid-growth-smart-pill-market-expected-2025/ 2018-01-25T14:03:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/doe-shires-restructuring-foreshadow-neuroscience-spin-off-divesture/ 2018-01-11T10:05:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/celgene-set-challenge-incyte-novartis-myelofibrosis-landscape/ 2018-01-15T10:04:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/mdma-become-psychiatrys-antibiotic/ 2018-01-10T14:16:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-supply-beigenes-tislelizumab-china/ 2021-10-25T09:25:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/syapse-roche-bolster-precision-medicine-cancer/ 2018-01-11T10:23:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rhythm-pharma-uses-wuxis-ai-obesity-disorder-therapy/ 2018-01-11T10:32:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/needleless-injections-used-in-zika-vaccine/ 2018-01-19T16:10:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/uncertain-times-brexit-effect-pharma/ 2018-01-10T13:00:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-agrees-review-mercks-ndas-hiv-drug-doravirine/ 2018-01-10T09:42:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/regeneron-forms-consortium-advance-human-gene-sequencing/ 2018-01-10T09:59:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teva-alder-sign-global-licence-agreement-anti-cgrp-therapy/ 2018-01-10T11:54:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-plans-acquire-tigenix-e520m/ 2018-01-09T09:50:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-alnylam-restructure-rnai-rare-disease-alliance/ 2018-01-09T09:56:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ablynx-rejects-novo-nordisks-acquisition-proposal/ 2018-01-09T11:51:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/beacon-enters-drug-discovery-collaboration-janssen/ 2018-01-08T10:15:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-grants-fast-track-designation-malaria-drug-tafenoquine/ 2018-01-08T10:21:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/celgene-purchase-impact-biomedicines-1-1bn-upfront/ 2018-01-08T13:12:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/venture-financing-biotech-firms-continues-growth-trend/ 2018-01-05T14:44:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/us-pharma-industry-holds-price-cap-pledge/ 2018-01-11T10:07:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/glaucoma-market-ten-year-forecast/ 2023-04-14T06:18:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-shenzhou-yiqiao-information-service-walvax-biotechnology-kangmei-pharmaceutical/ 2018-01-08T07:52:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/icr-study-finds-virus-potential-brain-tumour-treatment/ 2018-01-05T10:45:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-awards-breakthrough-designation-novartis-promacta/ 2018-01-05T10:36:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-orbimed-asia-partners-kadmon-holdings-ani-pharmaceuticals/ 2018-01-05T09:50:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/servier-treventis-develop-drugs-alzheimers-disease/ 2018-01-09T09:25:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/apollobio-develop-inovios-vgx-3100-greater-china/ 2018-01-04T10:15:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-sangamo-develop-zinc-finger-protein-therapy-als/ 2018-01-04T12:13:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-accepts-sbla-seattle-genetics-adcetris-hodgkin-lymphoma/ 2018-01-04T10:28:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/2017-sees-fewest-first-time-indications-awarded-fda-orphan-drug-designation-since-2009/ 2018-01-03T16:45:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/key-biotechnology-drivers-2018-will-surge-continue/ 2018-01-04T11:29:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/seysara-set-boost-stagnant-treatment-landscape-acne/ 2023-05-17T05:12:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/hiv-traditional-small-molecules-new-biologics/ 2018-01-03T11:45:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biocon-mylans-biosimilar-receives-brazilian-regulatory-approval/ 2018-01-03T11:13:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-faces-lawsuits-knee-amputations-due-invokana/ 2018-01-03T12:39:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ani-pharma-purchases-us-rights-four-astrazeneca-products/ 2018-01-03T11:23:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mallinckrodt-agrees-buy-sucampo-pharma-1-2bn/ 2018-01-02T11:49:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teva-pharmaceutical-launches-generic-version-reyataz-us/ 2018-01-09T12:12:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-accepts-nda-filing-gw-pharmaceuticals-epidiolex/ 2018-01-02T11:15:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/2017-biggest-news-stories-pharmaceutical/ 2018-01-04T11:34:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/seasons-greetings/ 2017-12-22T11:02:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bayers-partner-loxo-oncology-initiates-nda-larotrectinib/ 2017-12-22T10:46:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-agrees-manufacture-viral-vectors-bluebird-bio/ 2017-12-22T10:38:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-china-meheco-recordati-novartis/ 2017-12-22T10:22:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-strides-pharma-asia-glaxosmithkline/ 2017-12-22T10:32:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-technology-focus-issue-66/ 2023-04-12T06:21:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/look-bayers-top-performing-drugs/ 2017-12-21T13:41:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/look-astrazenecas-top-performing-drugs/ 2017-12-21T13:39:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/look-amgens-top-performing-drugs/ 2018-01-03T11:40:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/look-takedas-top-performing-drugs/ 2017-12-21T13:32:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-partners-uks-autifony-cns-therapeutics/ 2017-12-21T11:06:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-spark-therapeutics-luxturna-retinal-dystrophy/ 2017-12-21T11:02:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dice-genentech-enter-multi-year-research-collaboration/ 2018-01-09T09:35:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/oncology-strategic-alliances-q4-2017-focus-deals-organisations-heterogeneous-nature/ 2023-01-05T06:05:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-scientists-find-arthritis-treatment-effective-skin-cancer/ 2017-12-20T11:59:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/avista-pharma-completes-facility-upgrades-longmont-site-us/ 2017-12-20T12:06:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/otsuka-x-chem-advance-discovery-process-drug-compounds/ 2021-10-28T12:24:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/brexits-implications-uk-pharmaceutical-sector/ 2017-12-19T12:05:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/regeneron-isa-pharma-advance-immunotherapy-combination/ 2017-12-19T11:02:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cpnps-cellprotect-receives-orphan-drug-designation-ec/ 2017-12-19T11:17:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-publishes-two-draft-guidances-developing-targeted-therapies/ 2017-12-19T11:14:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/removing-barriers-data-sharing-pharmaceutical-rd/ 2017-12-15T11:54:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teva-unveils-restructuring-plan-improve-productivity/ 2017-12-18T09:54:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/emas-chmp-recommends-novo-nordisks-ozempic-diabetes/ 2017-12-19T13:13:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/crt-celgene-sign-drug-discovery-collaboration/ 2017-12-18T10:57:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/dbvs-viaskin-peanut-still-viable-despite-phase-iii-failure/ 2017-12-15T11:13:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-zealand-researchers-find-new-treatment-babies-born-small/ 2017-12-15T15:18:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/report-multiple-sclerosis-disease-modifying-therapies-market-witness-cagr-2-9/ 2017-12-15T11:37:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-shanghai-shyndec-pharmaceutical-aprecia-pharmaceuticals-daiichi-sankyo-company/ 2017-12-15T12:13:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-acquires-fda-approval-new-biosimilar-ixifi/ 2017-12-15T15:25:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/germanys-evotec-crtd-find-new-therapies-retinal-diseases/ 2023-03-30T07:38:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-allergan-philab-holdings/ 2017-12-15T11:30:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-acquires-exclusive-licence-ono-pharmas-anti-tumour-candidate/ 2017-12-14T15:12:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/daiichi-sankyo-puma-biotech-assess-combination-cancer-therapy/ 2017-12-14T11:59:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-gsks-drug-eosinophilic-granulomatosis-polyangiitis/ 2017-12-14T12:07:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/gene-silencing-therapy-offers-hope-huntingtons-disease/ 2023-05-09T06:41:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/artificial-intelligence-2018-27-predictions-business/ 2018-01-05T16:55:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/discontinuation-sanofis-c-difficile-vaccine-program-spell-good-news/ 2023-01-23T12:53:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/migraine-treatment-become-less-headache-revolutionary-new-solutions/ 2017-12-13T13:00:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-nih-funded-consortium-expand-trials-alzheimers/ 2017-12-13T10:09:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/northsea-therapeutics-secures-funding-develop-nash-drug/ 2023-05-17T05:01:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofis-short-acting-insulin-admelog-wins-fda-approval/ 2017-12-13T10:17:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/blame-game-pharma-trial-us-opioid-crisis/ 2023-01-17T09:56:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-recommends-eisais-kisplyx-renal-cell-carcinoma/ 2022-09-09T11:46:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/synlogic-ginkgo-bioworks-enter-drug-discovery-partnership/ 2017-12-12T11:32:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-accepts-bla-eli-lillys-galcanezumab-treat-migraine/ 2017-12-12T13:53:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/bringing-nhs-pharma-closer-together/ 2017-12-08T11:54:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-take-cell-design-labs-567m/ 2017-12-11T10:59:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-scientists-find-potential-therapy-ebola-virus-infection/ 2017-12-11T11:06:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/meiragtx-obtains-rare-disease-designation-gene-therapy-a001/ 2017-12-11T13:21:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/psoriatic-arthritis-will-eli-lillys-taltz-perform-novartiss-cosentyx/ 2017-12-08T09:44:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bluebird-bio-tc-biopharm-develop-new-cancer-immunotherapies/ 2017-12-08T12:26:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/icr-scientists-find-new-target-protein-cancer/ 2017-12-08T12:11:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-revance-therapeutics-gw-pharmaceuticals-valeant-pharmaceuticals-international/ 2017-12-07T21:33:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/carmot-amgen-identify-new-therapeutics-parkinsons/ 2017-12-08T12:17:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-cvs-health-corporation-neurosearch/ 2017-12-07T21:38:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/neurologists-additional-pml-cases-ms-not-major-concern-ocrevus/ 2017-12-13T10:19:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/jjs-darzalex-set-shake-frontline-treatment-multiple-myeloma/ 2017-12-07T11:50:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/new-approach-treating-schizophrenia/ 2017-12-07T10:20:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-life-sciences-industry-secures-government-sector-deal/ 2017-12-07T13:19:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/everest-offer-two-arena-pharma-drugs-asian-countries/ 2017-12-07T11:46:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-fda-approves-genentechs-avastin-glioblastoma/ 2017-12-07T11:43:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/the-impact-of-medicare-coverage-for-anti-obesity-interventions-html/ 2021-11-02T03:27:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/new-drug-harness-gut-bacteria-end-lactose-intolerance/ 2017-12-06T15:03:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/chinas-new-regulations-set-stage-partnerships-acquisitions/ 2021-11-22T08:16:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/accc-sues-novartis-gsk-false-marketing-voltaren-products/ 2017-12-06T12:33:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novembers-top-news-stories-2017/ 2022-08-17T11:26:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-launches-100m-initiative-address-hiv/ 2017-12-06T11:10:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/blue-oak-psychogenics-develop-new-brain-disorder-therapies/ 2023-08-11T04:03:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-astho-seeks-1bn-funding-opioid-epidemic/ 2017-12-05T12:57:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bayer-extends-research-collaboration-cancer-treatments/ 2017-12-05T11:24:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-acquires-licensing-rights-basileas-cresemba-china/ 2017-12-05T11:34:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/delivery-destination-mapping-nanoparticles-poor-sense-direction/ 2017-12-04T15:00:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/forecast-top-10-best-selling-drugs-oncology-2023/ 2017-12-04T12:02:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cvs-health-take-aetna-69bn/ 2017-12-04T12:06:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-accepts-marketing-application-trastuzumab-pegfilgrastim/ 2017-12-04T09:05:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astellas-acquires-drug-discovery-subsidiary-mitobridge/ 2017-12-04T09:00:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/national-academies-report-adds-fuel-to-fire-in-raging-us-drug-pricing-debates-html/ 2021-11-02T03:27:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cancer-genetics-icon-reduce-cancer-mortality-rate-india/ 2021-10-29T08:48:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-kaisa-group-holdings-zhongyuan-union-cell-gene-engineering/ 2017-12-01T12:17:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-grants-orphan-drug-status-shires-uc-treatment-shp647/ 2017-12-01T13:57:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-xiangxue-pharmaceutical-astrazeneca-vanc-pharmaceuticals/ 2017-12-01T10:31:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/portugal-researcher-create-3d-cancer-disease-models/ 2017-12-01T13:50:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/lifnano-can-nanotech-flip-switch-cure-multiple-sclerosis/ 2020-01-31T13:44:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/evocalcet-faces-stiff-competition-japans-ckd-induced-hyperparathyroidism-market/ 2017-11-30T10:38:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pharmaceutical-ma-deals-decline/ 2017-11-30T10:26:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-validates-bms-application-widen-cancer-therapy-indication/ 2017-11-30T14:15:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazenecas-regulatory-submission-accepted-tagrisso/ 2017-11-30T12:16:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-seeks-fda-approval-tafenoquine-treat-p-vivax-malaria/ 2017-11-30T12:20:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/boehringer-gains-ema-approval-cyltezo-eus-third-humira-biosimilar/ 2017-11-29T15:25:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/red-sage-ancient-chinese-herb-prevent-bone-loss/ 2023-01-04T11:12:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sobi-receives-approval-orfadin-treat-ht-1-patients-canada/ 2017-11-29T10:44:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-fda-grants-fast-track-status-stealths-elamipretide/ 2017-11-29T14:43:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bioge-alkermes-develop-alks-8700-ms-treatment/ 2017-11-29T15:00:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/diy-medicines-anarchic-fringe-drug-price-debate/ 2017-11-28T16:01:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hitgen-identify-new-small-molecule-leads-boehringer/ 2017-11-28T11:36:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pharming-submits-application-fda-ruconest-treat-hae/ 2023-03-31T10:38:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-submit-cdf-proposal-cancer-drug/ 2017-11-28T13:38:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/amsterdam-triumphs-is-the-netherlands-a-trojan-horse-for-pricing-and-drug-approval-reform-in-europe-html/ 2021-11-02T03:27:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/shingrix-effective-shingles-vaccine-huge-commercial-promise/ 2017-11-27T11:18:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-innoviva-file-snda-expanded-scope-trelegy-ellipta/ 2017-11-27T12:32:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/specialised-therapeutics-commercialise-pumas-nerlynx-breast-cancer/ 2017-11-27T11:57:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/acerus-grants-apsen-rights-market-natesto-brazil/ 2017-11-27T15:02:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/beactica-advance-lsd1-programme-glioblastoma-treatment/ 2017-11-24T12:05:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-eris-lifesciences-sichuan-languang-development-xiangxue-pharmaceutical-navamedic/ 2017-11-24T10:26:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-launches-tremfya-uk-treat-psoriasis/ 2017-11-24T12:10:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/report-singapores-pharmaceutical-market-witness-5-cagr-2021/ 2017-11-24T10:18:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-caligor-rx-zhejiang-jolly-pharmaceutical/ 2017-11-24T10:08:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/trackable-pills-big-benefits-big-brother/ 2017-11-23T11:24:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lead-pharma-sanofi-collaboration-autoimmune-diseases-achieves-third-milestone/ 2017-11-23T10:21:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-fda-approves-viiv-healthcares-juluca-regimen-treat-hiv-1/ 2017-11-23T12:09:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/study-finds-cellular-mechanisms-promote-pancreatitis-pancreatic-cancer/ 2023-06-09T07:34:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/inside-carb-x-can-new-model-research-fix-broken-antibiotic-market/ 2017-11-22T17:47:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tesaros-zejula-receives-ec-approval-treat-ovarian-cancer-europe/ 2017-11-22T11:48:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/study-finds-gastric-treatment-lansoprazole-may-target-tuberculosis/ 2017-11-22T12:00:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-cma-accuses-concordia-overcharging-nhs-thyroid-drug/ 2017-11-22T12:06:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/can-uk-stay-medicines-cutting-edge/ 2017-11-21T13:35:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/tax-reform-bill-puts-us-orphan-drug-act-threat/ 2017-11-21T11:45:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pharma-rd-adapting-personalised-future/ 2017-11-21T16:16:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-nccn-fund-new-projects-improve-breast-cancer-care/ 2017-11-21T10:24:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/samsung-bioepis-ontruzant-acquires-marketing-rights-cancer-europe/ 2017-11-21T10:53:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/study-finds-benzodiazepine-increases-mortality-alzheimers-patients/ 2022-07-11T08:56:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/nutraceuticals-held-back-regulatory-confusion/ 2017-11-20T15:37:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/acne-treatment-doxycyclines-side-effects-outweigh-benefits/ 2024-05-10T06:39:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bb2121-receives-ema-prime-eligibility-fda-btd-multiple-myeloma/ 2017-11-20T09:56:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-enzyme-identified-cuts-amino-acid-tyrosine-off-cytoskeleton/ 2017-11-20T10:31:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cue-biopharma-merck-develop-biologics-autoimmune-diseases/ 2017-11-20T11:17:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-shanghai-pharmaceutical-sapphire-hk-holdings-sumitomo-corporation-america/ 2021-11-30T11:45:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazenecas-faslodex-verzenio-receives-fda-approval-advanced-breast-cancer/ 2017-11-17T11:11:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-accepts-filing-alkermes-nda-schizophrenia-treatment/ 2017-11-17T11:17:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-valeant-pharmaceuticals-international-hikma-pharmaceuticals-yabao-pharmaceutical-group/ 2017-11-17T10:22:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/report-venezuelas-economic-crisis-hit-domestic-pharmaceutical-market/ 2017-11-17T10:30:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/support-use-inflectra-crohns-disease/ 2017-11-16T14:57:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/redefining-high-blood-pressure-ease-long-term-effects/ 2017-11-20T10:10:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/global-gene-osuccc-james-boost-cancer-research-south-asia/ 2017-11-16T12:06:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/shires-adynovi-receives-chmp-positive-opinion-haemophilia/ 2017-11-16T10:31:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-recommends-pfizers-palbociclib-treat-advanced-breast-cancer/ 2017-11-16T12:05:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-technology-focus-issue-65/ 2023-04-12T06:15:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/icer-nice-different/ 2017-11-15T11:15:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/juno-therapeutics-explores-car-t-trial-deaths/ 2022-07-11T08:56:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/mycite-first-pill-digital-tracking-system/ 2017-11-15T09:45:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/loxo-oncology-bayer-co-develop-cancer-drugs-1-55bn-deal/ 2017-11-15T11:51:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/european-commission-approves-gsks-benlysta-treat-sle-patients/ 2017-11-15T11:42:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/shanghai-pharma-buy-cardinal-health-china-business-1-2bn/ 2017-11-15T11:31:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pakistans-punjab-province-launch-novartis-access-treatments/ 2017-11-14T10:32:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-award-launched-support-ai-based-medical-research-uk/ 2017-11-14T10:38:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-idf-partner-support-global-type-2-diabetes-prevention/ 2017-11-14T10:45:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/will-argentinas-public-healthcare-reform-finally-accelerate-html/ 2021-11-02T03:29:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/rocking-us-generics-boat-indian-competition-fda-pressure/ 2021-12-02T05:07:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aquila-support-macrophages-immuno-oncology-programme/ 2023-06-30T04:32:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-fda-approves-mercks-prevymis-tablets/ 2017-11-13T11:21:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/value-in-healthcare-insights-from-ispor-html/ 2021-11-02T03:29:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-develop-principias-btk-inhibitor-multiple-sclerosis/ 2021-11-25T10:51:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cerenis-therapeutics-acquire-lypro-biosciences-assets/ 2017-11-10T13:36:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-egyptian-american-enterprise-fund-valeant-pharmaceuticals-international/ 2017-11-10T11:04:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-sarepta-therapeutics-cumberland-pharmaceuticals-cti-biopharma/ 2017-11-10T11:07:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/marking-milestones-north-american-cystic-fibrosis-conference-2017/ 2017-11-09T10:37:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/cystic-fibrosis-matching-medicines-mutations/ 2017-11-09T10:04:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-mina-develop-new-compounds-nash-disease/ 2017-11-09T10:50:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/spark-therapeutics-pfizer-amend-agreement-spk-9001-therapy/ 2017-11-09T11:16:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/better-diabetes-treatment-can-save-medicaid-over-4-billion-per-year-html/ 2021-11-02T03:29:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/octobers-top-stories-nih-found-new-target-proteins-anti-malaria-drugs-nci-discovered-new-way-combat-cancer/ 2017-11-10T17:12:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oxford-biodynamics-us-firm-advance-new-treatment-fibrosis/ 2017-11-08T11:40:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-submits-maa-ctl019-immunocellular-therapy/ 2017-11-08T11:45:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/vyzulta-approval-opens-new-avenues-glaucoma-treatment/ 2023-07-24T13:09:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-fda-approves-genentechs-zelboraf-treat-ecd/ 2017-11-07T10:58:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-grant-awarded-support-leukaemia-research-us/ 2017-11-07T11:10:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/metabolic-disorders-market-heavily-dominated-diabetes-drugs/ 2023-05-09T08:02:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/viivs-fostemsavir-positioned-treatment-resistant-hiv-patients/ 2022-07-11T08:56:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mallinckrodt-acquire-ocera-therapeutics-117m/ 2017-11-06T11:52:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/__trashed-3/ 2017-11-06T12:09:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/top-five-drivers-cardiovascular-market-growth/ 2017-11-03T15:13:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-hildred-capital-partners-novartis-neos-therapeutics/ 2017-11-03T12:09:45+00:00 daily 0.2